Clinical trial
Choice of Optimal Transcatheter Treatment for Mitral Insufficiency Registry
NCT04688190 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Choice of Optimal Transcatheter Treatment for Mitral Insufficiency Registry
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 1, 2020
- Completion date
- December 31, 2030
- Enrollment
- 1,000 (estimated)
- Sites
- 43
Conditions
As the registry lists them; a condition with its own page is linked.
mitral annular calcification, mitral regurgitation, mitral valve disease